Bendamustine plus Rituximab (BR) Chemoimmunotherapy and Maintenance Lenalidomide in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Wisconsin Oncology Network (WON) Study

被引：0

作者：

Chang, Julie E. ^{[1
]}

Zhang, Chong ^{[2
]}

Kim, KyungMann ^{[2
]}

Kirby, Rachel ^{[3
]}

Volk, Lynn ^{[3
]}

Werndli, Jae ^{[1
]}

Go, Ronald S. ^{[4
]}

Weiss, Matthias ^{[5
]}

Blank, Jules H. ^{[6
]}

Thompson, Michael A. ^{[7
]}

Farnen, John P.

Cole, Craig E.

Bseiso, Ali W. ^{[5
]}

Volk, Michael ^{[6
]}

Bayer, Gerald ^{[6
]}

Wassenaar, Tim ^{[7
]}

Mansky, Patrick ^{[8
]}

Traynor, Anne ^{[1
]}

Fenske, Timothy S. ^{[9
]}

Kahl, Brad S. ^{[1
]}

机构：

[1] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA

[2] Univ Wisconsin, Dept Biostat & Med Informat, Sch Med & Publ Hlth, Madison, WI USA

[3] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[4] Gundersen Lutheran Hlth Syst, Ctr Canc & Blood Disorders, La Crosse, WI USA

[5] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA

[6] St Vincent Reg Canc Ctr, Green Bay, WI USA

[7] ProHlth Care Reg Canc Ctr, Waukesha, WI USA

[8] Bellin Mem Hosp, Green Bay, WI USA

[9] Med Coll Wisconsin, Milwaukee, WI 53226 USA

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.3647.3647

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3647

引用

页数：2

共 50 条

[31] A DOSE ESCALATION STUDY OF IBRUTINIB WITH LENALIDOMIDE FOR RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Pollyea, D.
Gore, L.
Gutman, J.
Eckhardt, S. G.
Hagelstrom, N.
Coutre, S.
Thirman, M.
Byrd, J.
ANNALS OF ONCOLOGY, 2013, 24 : 33 - 33
[32] A Dose Escalation Study of Ibrutinib with Lenalidomide for Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Pollyea, Daniel A.
Coutre, Steven
Gore, Lia
Adler, Nichole
Harris, Pamela
Phelps, Mitch A.
Johnson, Amy J.
Ling, YongHua
Li, Hao
Gutman, Jonathan A.
Byrd, John C.
BLOOD, 2014, 124 (21)
[33] EXPOSURE RESPONSE (E-R) RELATIONSHIPS OF LISOCABTAGENE MARALEUCEL (LISO-CEL) MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Chen, Y.
Balasubramanian, N.
Cummings, J.
Lin, H.
Ou, S.
Tuazon, S.
Perna, S.
Ogasawara, K.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S87 - S87
[34] First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Brown, Jennifer R.
Hillmen, Peter
Eichhorst, Barbara
Lamanna, Nicole
O'Brien, Susan
Tam, Constantine S.
Qiu, Lugui
Kazmierczak, Maciej
Zhou, Keshu
Simkovic, Martin
Mayer, Jiri
Gillespie-Twardy, Amanda
Shadman, Mazyar
Ferrajoli, Alessandra
Ganly, Peter S.
Weinkove, Robert
Salmi, Tommi
Wu, Kenneth
Novotny, William
Jurczak, Wojciech
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S266 - S266
[35] Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Updated Follow-up of Transcend CLL 004
Siddiqi, Tanya
Gauthier, Jordan
Kenderian, Saad S.
Brander, Danielle M.
Dorritie, Kathleen
Soumerai, Jacob D.
Reidell, Peter A.
Shah, Nirav N.
Nath, Rajneesh
Andreadis, Charalambos
Ermann, Daniel A.
Ma, Shuo
Feldman, Tatyana
Solomon, Scott R.
Schuster, Stephen J.
Tuazon, Sherilyn A.
Perna, Serena K.
Ou, San-San
Rane, Neha
Papp, Eniko
Chen, Yizhe
Wierda, William G.
BLOOD, 2024, 144 : 4633 - 4635
[36] Transcend CLL 004: Phase 1 Cohort of Lisocabtagene Maraleucel (liso-cel) in Combination with Ibrutinib for Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Wierda, William G.
Dorritie, Kathleen A.
Munoz, Javier
Stephens, Deborah M.
Solomon, Scott R.
Gillenwater, Heidi H.
Gong, Lucy
Yang, Lin
Ogasawara, Ken
Thorpe, Jerill
Siddiqi, Tanya
BLOOD, 2020, 136
[37] Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
Costa, Luciano J.
Fanning, Suzanne R.
Stephenson, Joe, Jr.
Afrin, Lawrence B.
Kistner-Griffin, Emily
Bentz, Tricia A.
Stuart, Robert K.
LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 645 - 649
[38] Comparing Single-Agent Ibrutinib, Bendamustine Plus Rituximab (BR) and Ibrutinib Plus BR in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): An Indirect Comparison of the RESONATE and HELIOS Trials
Hillmen, Peter
Fraser, Graeme
Jones, Jeffrey
Rule, Simon
O'Brien, Susan
Dilhuydy, Marie Sarah
Jaeger, Ulrich
Grosicki, Sebastian
Cymbalista, Florence
Sun, Steven
Ninomoto, Joi
Mahler, Michelle
Cheng, Mei
Diels, Joris
Clow, Fong
Salman, Mariya
James, Danelle F.
Howes, Angela
Chanan-Khan, Asher
BLOOD, 2015, 126 (23)
[39] Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy
Sara Small
Shuo Ma
Current Hematologic Malignancy Reports, 2021, 16 : 325 - 335
[40] Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy
Small, Sara
Ma, Shuo
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (04) : 325 - 335

← 1 2 3 4 5 →